First Responder RT-CGM education program

Free on-demand course

Calling all First Responders:

Real-Time continuous glucose monitoring (RT-CGM) Awareness and diabetes Emergencies

We know that first responders care for many people experiencing diabetes-related emergencies, some of which can be life-threatening.

icon

Severe hypoglycemia has an annual prevalence of 30%-40%¹ and an annual incidence of 0.8-4.97 episodes per patient per year.^2,3 It can also be fatal.⁴

icon

Dexcom RT-CGM Systems track glucose levels and can warn people living with diabetes if their levels are going too low or high. Dexcom RT-CGM is also proven to reduce hypoglycemia-related emergency department visits and hospitalizations.⁵

Check out our first responder video series and share with a colleague!

In this video series offered by Dexcom, you will learn about the challenges of living with diabetes and why diabetes-related emergencies occur. We will share some emergency scenarios you may encounter on the job, and how RT-CGM can help prevent some of them.

Module 1: introduction

Overview of diabetes health challenges and how technology like RT-CGM can help people prevent some diabetes-related emergencies.

Module 2: Stigma and Diabetes

Living with diabetes can be challenging. Using person-first, strength-based language when talking about diabetes emergencies can improve relationships and help people seek appropriate care.

Module 3: What is real-time cgm?

Learn about the benefits of using RT-CGM rather than blood glucose monitoring and an A1C lab value to manage diabetes.

Compatible smart devices sold separately: dexcom.com/compatibility.

module 4: hypoglycemia emergencies

Most people living with diabetes are at risk for hypoglycemia emergencies. Learn about hypoglycemia, hypoglycemia unawareness, and how RT-CGM may help prevent emergency situations.

module 5: hyperglycemia emergencies

Diabetic ketoacidosis, or DKA, is a life-threatening emergency. Learn who is at risk and how RT-CGM can alert people with diabetes before their glucose rises to a dangerous level.

module 6: emergency scenarios: older adults and repeated 911 calls

This module explores two specific situations: older adults at higher risk for diabetes emergencies and individuals who are at risk for repeated severe hypoglycemia episodes.

module 7: dexcom continuous glucose monitoring systems

Learn more about the Dexcom G7 CGM System and why trend arrows, predictive alerts, and the ability to share glucose data with a circle of support^‡,† can help people better manage diabetes.

Smart device sold separately.*

Course instructors:

Deb Greenwood Deborah Greenwood, PhD, RN, BC-ADM, CDCES, FADCES

Dexcom

Deborah Greenwood is a clinical nurse specialist, certified diabetes care and education specialist, and researcher. She is also a Senior Manager of Clinical Education at Dexcom, leading a team focused on increasing awareness of the benefits of RT-CGM in type 2 diabetes, primary care, pharmacy and population health. She is also an Adjunct, Assistant Professor at University of Utah College of Nursing and has written and educated about diabetes technology for many years. Deborah has many friends who live with diabetes and is a passionate advocate for using person-first, strength-based language when talking about diabetes. In her free time, she writes a diabetes blog and volunteers for multiple diabetes non-profits. She also served as the 2015 President of the Association of Diabetes Care and Education Specialists.

Frances Damian

Frances Damian, MS, RN, NEA-BC

Boston Children’s Hospital

Frances Damian specializes in pediatric emergency nursing and served as the Nursing Director in Emergency Services for close to 30 years. She is currently the Manager of Multispecialty Clinics for two satellite locations of Boston Children’s Hospital. Fran has lived with type 1 diabetes (T1D) for 27 years, and for more than 20 years has managed it with insulin pumps and CGM systems. She relies on CGM technology to optimize her diabetes management and overall health. Fran volunteers as a nurse at Diabetes Training Camp, an education and sports performance camp for adults with T1D, and leads the ongoing development of a program for teen athletes with T1D and their parents.

Resources

Learn more by exploring the links below:

Speaking the language of diabetes (PDF)

Changing the conversation about diabetes (Video)

‡Separate Follow app and internet connection required. To view a list of compatible devices, visit dexcom.com/compatibility. †Always depend on your G& app to manage your diabetes, not your Followers’. Always confirm your glucose information on your G7 app, receiver, or blood glucose meter, before making any treatment decision.

1 McCrimmon RJ and Sherwin RS. Diabetes. 2010;59(10):2333–2339. 2 Edridge CL, et al. PLoS One. 2015;10(6):e0126427. 3 Ratzki-Leewing, et al. Diabetes. 2022;(Supplement 1):372-P. 4 Tanenberg RJ, et al. Endocr Pract. 2010;Mar-Apr;16(2):244-8. 5 Karter AJ, et al. JAMA. 2021;325(22):2273-2284.

LBL-1001665 REV002

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Request a Visit from a Dexcom Representative

Request for Patient Materials on Dexcom CGM

More Information on Dexcom

Request a Sample

Other

PLEASE NOTE: THE WEB SAMPLE REQUEST PROGRAM IS CURRENTLY DOWN FOR MAINTENANCE AND NOT PROCESSING REQUESTS. THE PROGRAM WILL RETURN IN MAY. WE APOLOGIZE FOR THE INCONVENIENCE.

Do not include prefix (Mr., Mrs., Dr.)

As listed on Provider's medical license (no MD, Jr., Sr.)

Please use the Provider's NPI

Is your patient on a connected pump device?

Yes

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense samples of the Dexcom G6 Continuous Glucose Monitoring System and/or Dexcom‘s next generation product, Dexcom G7 (the "Samples"). I represent that I am requesting the Samples for evaluation purposes and that I will not (i) sell, resell, barter, return for credit or seek reimbursement for the use of the Samples, or (ii) for professional services for dispensing or evaluating the Samples, I also agree to inform my patients that they should not submit claims for reimbursement to any third party for any Samples.

The Samples are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither devices nor receivers are included in the Samples. Accordingly, and in light of the applicable G6 or G7 Dexcom Instructions for Use, you should dispense Samples only to a patient who (or whose authorized caregiver), in the exercise of your clinical judgment, (i) has reliable access to a compatible smart device and/or automated insulin delivery system, and (ii) is capable of safely using the Samples with their smart device, without the need for a separate dedicated receiver.

Please note that Medicare will reimburse for sensors only if the beneficiary also uses a receiver covered by Medicare. Accordingly, it is appropriate to give Samples to Medicare patients only if they have (in the case of the G6 Samples) or would be eligible to obtain (in the case of the G7 Samples), a Medicare-covered receiver.

You agree that you will not provide the Samples to any patients that are beneficiaries under the Maine or Colorado state Medicaid programs. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Samples. I agree not to reuse any Samples. I acknowledge that Dexcom provides no warranties for the Samples other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Samples, and I agree to store and use these Samples in a manner consistent with the applicable Dexcom Instructions for Use. Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

LBL-1004145 Rev001

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense these Dexcom G6 Continuous Glucose Monitoring Systems and/or Dexcom‘s next generation product, Dexcom G7 (the "Dexcom Education Devices") which are provided in the quantities listed above.

The Dexcom Education Devices are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither smart devices nor receivers are included with the Dexcom Education Devices. I understand that these Dexcom Education Devices are being requested for me and other healthcare professionals ("HCPs") for evaluation purposes to learn more about the Dexcom Education Devices and experience the benefits of the Dexcom Education Devices through a product demonstration, and that each HCP will need a compatible smart device for the product demonstration.

I acknowledge that Dexcom provides no warranties for the Dexcom Education Devices other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use, and agree not to reuse any Dexcom Education Devices. I agree to receive, store, distribute, and/or use these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use and device labeling. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Dexcom Education Devices. I understand and agree to properly dispose of the Dexcom Education Devices immediately following the completion of the product demonstration. The Dexcom Education Devices are being provided at no cost, without any expectation of remuneration, HCPs have no obligations under the federal supply schedule contract for participating in the product demonstration, and Dexcom waives any rights under this contract or applicable law to pursue a claim for the costs associated with the Dexcom Education Devices.

Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.